Actively Recruiting
METABolic Deterioration in HTX Determines Outcomes
Led by Heinrich-Heine University, Duesseldorf · Updated on 2026-01-28
270
Participants Needed
1
Research Sites
340 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
CONDITIONS
Official Title
METABolic Deterioration in HTX Determines Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Planned or completed heart transplantation
- Provided informed consent
You will not qualify if you...
- No informed consent provided
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University-Hospital Düsseldorf Division of Cardiology, Pneumology and Angiology
Düsseldorf, North Rhine-Westphalia, Germany, 40225
Actively Recruiting
Research Team
A
Amin Polzin, Prof.
CONTACT
F
Fabian Voß, Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here